Access2Bone Announces Accreditation by The American Association of Tissue Banks
The company seeks to supply effective bone void fillers for patients with an exhausted bone metabolism....
The company seeks to supply effective bone void fillers for patients with an exhausted bone metabolism....
Opus Mg Set is a magnesium-based settable bone void filler for orthopedic procedures. ...
The injectable bone substitute is now FDA 510(k) cleared for augmenting suture anchor fixation....
The clearance follows existing clearances by the FDA for the use of MagnetOs Granules and MagnetOs Putty in the spine....
Maxx-PRP is a next-gen device to concentrate autologous whole blood for the safe and rapid preparation of platelet-rich plasma....
The first patient has been treated in a study to investigate OssDsign Catalyst in patients undergoing spinal fusion....
The Phase III study with JTA-004 viscosupplement did not meet the primary and consequently the key secondary endpoints....
Published data show that i-FACTOR is not only cost-effective compared to autograft in ACDF, but is the dominant economic strategy....
OssDsign Catalyst is a synthetic bone graft that stimulates the formation of healthy bone tissue in spinal fusion surgeries....
The intra-articular single-injection viscosupplement is intended to treat knee osteoarthritis in Taiwan, through TCM Biotech International....
Login
Register for a free account
As a guest member you get access to more articles and videos every month.